Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,743 | 19,108 | 18,932 | 17,814 | 16,030 |
| Receivables | 99,129 | 97,660 | 96,733 | 98,159 | 95,449 |
| Inventories | 29,104 | 30,025 | 29,993 | 29,341 | 29,426 |
| TOTAL | $153,245 | $155,361 | $156,295 | $157,379 | $151,644 |
| Non-Current Assets | |||||
| PPE Net | 81,342 | 79,045 | 79,709 | 79,105 | 79,622 |
| Intangibles | 139,338 | 139,411 | 139,499 | 139,597 | 139,672 |
| Other Non-Current Assets | 20,676 | 22,223 | 17,884 | 19,067 | 17,859 |
| TOTAL | $241,356 | $240,679 | $237,092 | $237,769 | $237,153 |
| Total Assets | $394,601 | $396,040 | $393,387 | $395,148 | $388,797 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,544 | 169 | 881 | 1,927 | 2,976 |
| Accounts payable and accrued liabilities | 32,557 | 26,809 | 27,848 | 28,997 | 28,632 |
| Accrued Expenses | 17,371 | 20,624 | 21,279 | 21,307 | 22,920 |
| TOTAL | $69,556 | $66,294 | $63,600 | $65,063 | $67,411 |
| Non-Current Liabilities | |||||
| Long Term Debt | 86,104 | 90,105 | 102,109 | 112,216 | 110,224 |
| Deferred Revenues | 3,233 | 3,464 | 2,965 | 2,982 | 2,632 |
| Other Non-Current Liabilities | 24,684 | 24,411 | 22,663 | 22,597 | 20,866 |
| TOTAL | $110,788 | $114,516 | $124,772 | $134,813 | $131,090 |
| Total Liabilities | $180,344 | $180,810 | $188,372 | $199,876 | $198,501 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,668 | 51,687 | 52,151 | 52,139 | 52,070 |
| Common Shares | 474 | 473 | 468 | 489 | 484 |
| Retained earnings | 141,448 | 136,699 | 129,210 | 118,960 | 110,237 |
| Other shareholders' equity | -497 | -4,297 | -6,924 | -6,373 | -2,757 |
| TOTAL | $214,257 | $215,230 | $205,015 | $195,272 | $190,296 |
| Total Liabilities And Equity | $394,601 | $396,040 | $393,387 | $395,148 | $388,797 |